Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
Two physicians offer commentaries on the best course of action for a part-time janitor with no health insurance to receive the proper standard of care for his chronic recurrent prostatitis.
Two physicians offer commentaries on the best course of action for a part-time janitor with no health insurance to receive the proper standard of care for his chronic recurrent prostatitis.
An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in.